Introduction to Cardiovascular Disorders By Dr. Hanan Said Ali - PowerPoint PPT Presentation

1 / 53
About This Presentation
Title:

Introduction to Cardiovascular Disorders By Dr. Hanan Said Ali

Description:

Cardiac Stress Testing Cont ... dipyridamole and adenosine Echocardiography Echocardiography is a non invasive ultrasound test used to examine the size, shape, and ... – PowerPoint PPT presentation

Number of Views:179
Avg rating:3.0/5.0
Slides: 54
Provided by: Tosh157
Category:

less

Transcript and Presenter's Notes

Title: Introduction to Cardiovascular Disorders By Dr. Hanan Said Ali


1
Introduction to Cardiovascular DisordersBy Dr.
Hanan Said Ali
2
Learning Objectives
  • Identify Anatomy of the Heart .
  • Enumerates the etiology of cardiovascular
  • diseases.
  • Identify Cardiac Signs and Symptoms.
  • Discuses different diagnostic measures for
  • cardiovascular diseases.
  • List the treatment modalities for cardiovascular
  • diseases.

3
What are The Anatomy of the Heart ?
  • The heart is a hollow, muscular organ located
    in the centre of the thorax. It composed of
    three layers .The inner layer,or endocardium ,
    the middle layer, or myocardium,the exterior
    layer of the heart is called the epicardium.
    The right heart, made up of the right atrium
    andright ventricle The left side of the heart,
    composed of the left atrium and left ventricle

4
Anatomy of the Heart Cont.
5
Anatomy of the Heart Cont.
6
Cardiac Cycle
  • It has two phases
  • (A) Diastole ventricles relax fill with
  • blood (This is 2/3 of the
  • cardiac
    cycle.)
  • (B) Systolic heart contracts pushes
  • blood out of the ventricles
    to
  • (i) the lungs
  • (ii) systemic arteries

7
Etiology
  • Heredity
  • Increasing age
  • Gender
  • Hypercholesterolemia
  • Smoking
  • Diabetes
  • Physical inactivity
  • Obesity
  • Stress

8
Cardiac Signs and Symptoms
  • Chest pain, chest discomfort ,angina pain
  • Assessing Signs and Symptoms
  • Where is your pain (ask patient to point to
    location on chest)
  • What does the pain feel like? (pressure,
    heaviness, burning)
  • How severe is it on a scale of 0 to 10?
  • What causes the pain? (exertion, stress)

9
Cardiac Signs and Symptoms Cont.
  • Does anything relieve it? (rest, or
    nitro-glycerine)
  • Does it spread to your arms, neck, jaw,
    shoulders, or back? , How long does the pain
    last?
  • Do you have any additional symptoms? (shortness
    of breath, palpitations, dizziness, sweating)

10
Cardiac Signs and Symptoms Cont.
  • Shortness of breath, oedema, weight gain
  • Assessing Signs and Symptoms
  • When did you first notice feeling short of
    breath?
  • Do you have a cough? If yes, what do you cough
    up?
  • What makes you short of breath? Does anything
    make your breathing better or worse?

11
Cardiac Signs and Symptoms Cont.
  • What activities are you no longer able to do
    because you are short of breath?
  • Do you ever wake up at night feeling short of
    breath?
  • Do you get up at night to urinate? Have you
    noticed an increase or decrease in the amount you
    usually urinate?

12
Cardiac Signs and Symptoms Cont.
  • Have you noticed any weight gain or swelling in
    your feet, ankles, legs, or abdomen (sacrum if
    bedridden)?
  • How many pillows do you sleep on, and has this
    changed recently?
  • Do you sleep in your bed, or do you breathe
    easier sleeping in a chair?

13
Cardiac Signs and Symptoms Cont.
  • Assessing Signs and Symptoms
  • Palpitations
  • Do you ever feel your heart racing, skipping
    beats, or
  • pounding?
  • Do you ever feel lightheaded or dizzy?
  • Are there any other symptoms that occur at the
    same
  • time?
  • How much caffeine do you consume?

14
Cardiac Signs and Symptoms Cont.
  • Do you use tobacco (cigarettes, cigars)?
  • Do you use any other stimulants?
  • Have there been any changes in the amount of
    stress you experience?
  • How would you describe your usual activity
    level

15
Cardiac Signs and Symptoms Cont.
  • Assessing Signs and Symptoms
  • Fatigue
  • How would you describe your usual activity
    level?
  • What is your current activity level?
  • What were you able to do 1 month and 6 months
    ago?
  • What activities can you no longer do because of
    fatigue?

16
Cardiac Signs and Symptoms Cont.
  • Do you feel rested when you wake up in the
    morning?
  • Can you rest during the day?
  • How often do you awaken at night, and for what
    reason?

17
Cardiac Signs and Symptoms Cont.
  • Assessing Signs and Symptoms
  • Dizziness, syncope
  • Do you ever feel dizzy or lightheaded?
  • Do you ever pass out or have fainting spells?
  • Does this happen when you move from a lying to
    a sitting or standing position?

18
Cardiac Signs and Symptoms Cont.
  • Do you strain while having a bowel movement or
    when urinating?
  • Have you been urinating more than usual?
  • Have you decreased the amount of fluids you
    normally drink?
  • Do you have headaches?

19
Laboratory TestsCardiac Enzyme Analysis
  • Enzymes are released from injured cells when the
    cell membranes rupture.
  • Most enzymes are nonspecific in relation to the
    particular organ that has been damaged.
  • Certain isoenzymes, however, come only from
    myocardial cells and are released when the cells
    are damaged by sustained hypoxia, resulting in
    infarction.

20
Laboratory TestsCardiac Enzyme Analysis Cardiac
Enzyme Analysis
  • Creatine kinase (CK) and its isoenzyme CK-MB
  • are the most specific enzymes analyzed in acute
    MI.
  • Total Creatinine Phosphokinase (CPK)30 - 200
    U/L
  • CK..... 50 80 U/L CPK-MB.. 0 - 8.8 ng/m

21
Cardiac Enzyme Analysis Cont.
  • Troponin I
  • Is new laboratory test and is a contractile
    protein found only in cardiac muscle. After
    myocardial injury, elevated serum troponin I
    levels can be detected within 3 to 4 hours they
    peak in 4 to 24 hours and remain elevated for 1
    to 3 weeks.
  • Normal level ....... 0 0.4 ng/ml

22
CHOLESTEROL LEVELS
  • Cholesterol (normal level less than 200 mg/dL)
  • Elevated cholesterol levels are known to increase
    the risk for coronary artery disease.
  • Factors that contribute to variations in
    cholesterol levels include age, gender, diet,
    exercise patterns, and stress levels.

23
CHOLESTEROL LEVELS Cont.
  • LDLs (normal level less than 130 mg/dL)
  • One harmful effect of LDL is the deposition of
    these substances in the walls of arterial
    vessels. Elevated LDL levels are associated with
    a greater incidence of coronary artery disease.
  • HDLs (normal range in males 35 to 65 mg/dL,
    normal range in females 35 to 85 mg/dL) have a
    protective action.
  • Triglycerides (normal range 40 to 150 mg/dL),

24
SERUM ELECTROLYTE LEVELS
  • the serum sodium level reflects relative fluid
    balance. Generally, hyponatremia (low sodium
    level) indicates fluid excess and hypernatremia
    (high sodium level) indicates fluid deficit.
  • Serum potassiumA decrease in potassium causes
    cardiac irritability and predisposes the patient
    receiving a digitalis preparation to digitalis
    toxicity and dysrhythmias.
  • The effect of an elevated serum potassium level
    is myocardial depression and ventricular
    irritability.

25
BLOOD UREA NITROGEN LEVEL
  • In the patient with cardiac disease, an elevated
    blood urea nitrogen level may reflect reduced
    renal perfusion (from decreased cardiac output)
    or intravascular fluid volume deficit (from
    diuretic therapy)
  • SERUM GLUCOSE LEVEL
  • The serum glucose level is important to monitor
    because many patients with cardiac disease also
    have diabetes mellitus.

26
COAGULATION STUDIES
  • The values of PTT is used to assess patients
    receiving heparin therapy. Patients receiving
    heparin have their PTT levels maintained at 1.5
    to 2.5 times their baseline values
  • (reference range, 25 to 38 seconds).
  • Prothrombin time (PT)
  • is used to monitor patients receiving therapeutic
    anticoagulation with warfarin.
  • (reference range, less than 13 seconds).

27
Chest X-Ray and Fluoroscopy
  • A chest x-ray usually is obtained to determine
    the size, contour, and position of the heart.
  • It reveals cardiac and pericardial
    calcifications and demonstrates physiologic
    alterations in the pulmonary circulation.
  • Correct placement of cardiac catheters, such as
    pacemakers and pulmonary artery catheters, is
    also confirmed by chest x-ray.

28
Electrocardiography
  • It is a graphic recording of the electrical
    activity
  • of the heart.
  • The ECG is obtained by placing disposable
    electrodes in standard positions on the skin of
    the chest wall and extremities.
  • The 12-lead ECG is particularly useful in
    diagnosing dysrhythmias, conduction
    abnormalities, enlarged heart chambers,
    myocardial ischemia or infarction.

29
Continuous ECG Monitoring
  • Continuous ECG monitoring is standard for
    patients at high risk for dysrhythmias.
  • This monitor is a small tape recorder that
    continuously (from 10 to 24 hours) documents the
    hearts electrical activity on a magnetic tape.
  • The patient keeps a diary of activity, noting the
    time of any symptoms, experiences, or unusual
    activities performed.

30
TRANSTELEPHONIC MONITORING
  • The patient attaches a specific lead system for
    transmitting the signals and places a telephone
    mouthpiece over the transmitter box the ECG is
    recorded and evaluated at another location.
  • This method is often used for diagnosing
    dysrhythmias and in follow-up evaluation of
    permanent cardiac pacemakers.

31
Cardiac Stress Testing
  • It include three types of test
  • The exercise stress test.
  • The pharmacologic stress test.
  • And more recently the mental or emotional stress
    test, mental stress induced, for example, when
    the patient performs a mental arithmetic test
    evokes a myocardial ischemia response similar to
    that evoked by conventional exercise testing.

32
Cardiac Stress Testing Cont.
  • Exercise Stress Testing
  • the patient walks on a treadmill (most common) or
    pedals a stationary bicycle.
  • During the test, the following are monitored
  • two or more ECG leads for heart rate, rhythm, and
    ischemic changes, BP, skin temperature, physical
    appearance, perceived exertion, and symptoms
    including chest pain, dyspnea, dizziness, leg
    cramping, or fatigue.

33
Cardiac Stress Testing Cont.
  • the patient is instructed to fast for 4 hours
    before the test and to avoid stimulants such as
    tobacco and caffeine.
  • The physician may instruct patients not to take
    certain cardiac medications, such as beta
    blockers, before the test.
  • Clothes and sneakers or rubber-soled shoes
    suitable for exercising are to be worn

34
Cardiac Stress Testing Cont.
  • Pharmacologic Stress Testing
  • Two vasodilating agents, dipyridamole (Persantin)
    and adenosine administered intravenously are used
    to mimic the effects of exercise by maximally
    dilating the coronary
  • arteries.
  • Dobutamine is another medication that may be used
    for patients who cannot exercise.

35
  • patients are instructed not to eat or drink
    anything for at least 4 hour before the test.
  • This includes chocolate, caffeine, caffeine-free
    coffee, tea.
  • Patients taking aminophylline or theophylline are
    instructed to stop taking these medications for
    24 to 48 hours before the test because it block
    the effects of dipyridamole and adenosine

36
Echocardiography
  • Echocardiography is a non invasive ultrasound
    test used to examine the size, shape, and motion
    of cardiac structures.
  • It involves the transmission of high frequency
    sound waves into the heart through the chest wall
    and the recording of the return signals.
  • Other techniques, such as Doppler and color flow
    imaging echocardiography, show the direction and
    velocity of the blood flow through
  • the heart.

37
Echocardiography
38
(No Transcript)
39
Transesophageal Echocardiography
  • A small transducer through the mouth and into the
    esophagus.
  • provides clearer images because ultrasound waves
    are passing through less tissue.
  • It used in detecting and evaluating the severity
    of coronary artery disease.
  • The patient must be assessed before TEE for a
    history of dysphagia or radiation therapy to the
    chest that would increase the risk for
    complications.

40
Transesophageal Echocardiography
  • Gel applied to the skin helps transmit the sound
    waves.
  • The test takes about 30 to 45 minutes.
  • In preparation for a TEE study, the following
    information is reviewed
  • The patient must fast for 6 hours before the
    study.
  • An intravenous line is started for
    administering dobutamine and a sedative.
  • The throat is anesthetized before the probe is
    inserted.
  • BP and the ECG are monitored throughout the
    study.

41
Radionuclide Imaging
  • Myocardial Perfusion Imaging
  • Thallium 201, a radioisotope, is used to assess
    myocardial perfusion.
  • A dose of thallium 201 is injected into the
    intravenous line, images are taken immediately.
  • Areas that do not show thallium uptake are noted
    as defects and indicate either an area of
    infarction or stress-induced myocardial ischemia.

42
Radionuclide Imaging cont.
  • Technetium (Tc-99m) is a newer and better
    radioisotope used for cardiac imaging.
  • The patient may be concerned about receiving a
    radioactive substance and needs to be assured
    that these tracers are safe, having radiation
    exposure similar to that of other diagnostic
    x-rays.
  • No post procedure radiation precautions are
    necessary.

43
Cardiac Catheterization
  • Is an invasive diagnostic procedure in which
    radiopaque arterial and venous catheters are
    introduced into selected blood vessels of the
    right and left sides of the heart.
  • Is used most commonly to assess coronary artery
    patency and to determine if revascularization
    procedures are necessary

44
Cardiac catheterization Cont.
Coronary dilatation
Cardiac catheterization
45
Cardiac Catheterization cont.
  • During cardiac catheterization, the patient will
    have an intravenous line in place,
  • BP and ECG tracings are continuously monitored.
  • Resuscitation equipment must be readily available
    during the procedure because the introduction of
    catheters into the ventricles can induce
    potentially fatal dysrhythmias.

46
Cardiac Catheterization cont.
  • The patient is assessed before the procedure for
    previous reactions to contrast agents or
    allergies to shellfish.
  • Diagnostic cardiac catheterizations are commonly
    performed on an outpatient basis and require 8
    hours or less of bed rest for recovery.

47
Angiography
  • Cardiac catheterization is usually performed with
    angiography, a technique of injecting a contrast
    agent into the vascular system to outline the
    heart and blood vessels.
  • Common sites for selective angiography are the
    aorta, the coronary arteries, and the right
  • and left sides of the heart.

48
Angiography
  • NURSING INTERVENTIONS
  • Instruct the patient to fast, usually for 8 to 12
    hours, before the procedure.
  • Prepare the patient for the expected duration of
    the procedure indicate that it will involve
    lying on a hard table for less than 2 hours.
  • Reassure the patient that mild sedatives will be
    given intravenously to relieve anxiety.

49
Cardiac Catheterization cont.
  • Nursing responsibilities after cardiac
    catheterization may include the following
  • Observe the catheter access site for bleeding or
    hematoma formation, and assess the peripheral
    pulses in the affected extremity. Observe for
    dysrhythmias
  • Evaluate temperature and color of the affected
    extremity
  • and any patient complaints of pain, numbness, or
    tingling
  • sensations in the affected extremity to
    determine signs of
  • arterial insufficiency.

50
Hemodynamic Monitoring
  • Central Venous Pressure Monitoring
  • The CVP, the pressure in the vena cava or the
    right atrium, is used to assess right ventricular
    function and venous blood return to the right
    heart.
  • The range for a normal CVP is 0 to 8 mm Hg
  • Before insertion of a CVP catheter, the site is
    prepared by shaving
  • if necessary and cleansing with an antiseptic
    solution.
  • A local anesthetic may be used.

51
Central Venous Pressure Monitoringcont.
  • The physician threads a single-lumen or
    multilumen catheter through the external jugular,
    or femoral vein into the vena cava just above or
    within the right atrium.
  • Once the CVP catheter is inserted, it is secured
    and a dry sterile dressing is applied.
  • The most common complications of CVP monitoring
    are infection and air embolism.

52
Treatment modalities
  • Pharmacologic therapy
  • Control risk factors
  • Transmyocardial laser revascularization
  • Coronary artery bypass grafting (CABG)
  • Revascularization
  • -Invasive interventional procedures Percutaneous
    Transluminal Coronary Angioplasty (PTCA)
  • -Directional Coronary Atherectomy (DCA)
  • -Laser ablation
  • -Intracoronary stent

53
  • Thank You
Write a Comment
User Comments (0)
About PowerShow.com